Edison Healthcare Insight: March 2022
Enjoyed this read?
Stay up to date with our latest research.
BACK TO NEWS
Related articles
Press Releases and Media
Executive Interview HotCopper with Dr Steven Gourlay: Xanamem: Alzheimer’s breakthrough set for 2025, 2026
HotCopper • March 5, 2025
Press Releases and Media
The furore over how to treat Alzheimer’s just got a lot more complicated
The Australian • February 27, 2025
Press Releases and Media
Actinogen announces peer-reviewed clinical pharmacology manuscript for Xanamem (emestedastat) published in Clinical Pharmacology in Drug Development journal
PR Newswire • February 12, 2025